Assessment of Alcon's Ocular Image Quantification System

NCT01282138 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Conjunctivitis

Interventions

DRUG: Olopatadine hydrochloride, 0.1% ophthalmic solution (Patanol)
OTHER: Dextran 70 0.1%, hydroxypropyl methylcellulose 0.3% (Tears Naturale II)

Sponsor

Alcon Research